Acadia Healthcare (NASDAQ:ACHC) Releases FY 2024 Earnings Guidance

Acadia Healthcare (NASDAQ:ACHC) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share guidance of 3.350-3.450 for the period, compared to the consensus earnings per share estimate of 3.520. The company issued revenue guidance of $3.2 billion-$3.2 billion, compared to the consensus revenue estimate of $3.2 billion. Acadia Healthcare also updated its FY24 guidance to $3.35-$3.45 EPS.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Barclays lowered their target price on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a research note on Monday, September 30th. Royal Bank of Canada reiterated an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a research note on Friday, September 20th. Cantor Fitzgerald restated a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Finally, KeyCorp initiated coverage on Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. One research analyst has rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $86.67.

Acadia Healthcare Stock Down 1.6 %

Acadia Healthcare stock traded down $0.67 during trading hours on Friday, hitting $42.02. The company had a trading volume of 2,707,760 shares, compared to its average volume of 981,637. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.18 and a quick ratio of 1.18. Acadia Healthcare has a fifty-two week low of $41.75 and a fifty-two week high of $87.77. The firm’s fifty day moving average is $65.72 and its 200-day moving average is $67.79. The firm has a market capitalization of $3.90 billion, a P/E ratio of 13.78, a price-to-earnings-growth ratio of 1.50 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.28%. The company’s revenue was up 8.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.91 earnings per share. On average, research analysts forecast that Acadia Healthcare will post 3.51 earnings per share for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.